Arcadia Biosciences Inc (RKDA) - Total Assets
Based on the latest financial reports, Arcadia Biosciences Inc (RKDA) holds total assets worth $8.58 Million USD as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See Arcadia Biosciences Inc (RKDA) net assets for net asset value and shareholders' equity analysis.
Arcadia Biosciences Inc - Total Assets Trend (2012–2024)
This chart illustrates how Arcadia Biosciences Inc's total assets have evolved over time, based on quarterly financial data.
Arcadia Biosciences Inc - Asset Composition Analysis
Current Asset Composition (December 2024)
Arcadia Biosciences Inc's total assets of $8.58 Million consist of 68.4% current assets and 31.6% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 31.4% |
| Accounts Receivable | $1.18 Million | 8.7% |
| Inventory | $904.00K | 6.7% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $39.00K | 0.3% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2012–2024)
This chart illustrates how Arcadia Biosciences Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see how much is Arcadia Biosciences Inc worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Arcadia Biosciences Inc's current assets represent 68.4% of total assets in 2024, an increase from 59.0% in 2012.
- Cash Position: Cash and equivalents constituted 31.4% of total assets in 2024, down from 40.1% in 2012.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2012.
- Asset Diversification: The largest asset category is accounts receivable at 8.7% of total assets.
Arcadia Biosciences Inc Competitors by Total Assets
Key competitors of Arcadia Biosciences Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Orkla ASA
OL:ORK
|
Norway | Nkr88.70 Billion |
|
New Hope Dairy Co Ltd
SHE:002946
|
China | CN¥9.38 Billion |
|
Yankershop Food Co Ltd
SHE:002847
|
China | CN¥4.06 Billion |
|
Bellring Brands LLC
NYSE:BRBR
|
USA | $1.06 Billion |
|
Shandong Bailong Chuangyuan Bio-Tech Co. Ltd.
SHG:605016
|
China | CN¥2.58 Billion |
|
Yantai China Pet Foods Co Ltd
SHE:002891
|
China | CN¥5.36 Billion |
|
Xinjiang Guannong Fruit & Antler Group Co Ltd
SHG:600251
|
China | CN¥5.94 Billion |
|
Xiamen Kingdomway Group Co
SHE:002626
|
China | CN¥8.38 Billion |
Arcadia Biosciences Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.67 | 4.60 | 5.02 |
| Quick Ratio | 3.03 | 4.24 | 4.42 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $6.10 Million | $8.38 Million | $25.38 Million |
Arcadia Biosciences Inc - Advanced Valuation Insights
This section examines the relationship between Arcadia Biosciences Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.57 |
| Latest Market Cap to Assets Ratio | 0.14 |
| Asset Growth Rate (YoY) | -31.4% |
| Total Assets | $13.52 Million |
| Market Capitalization | $1.94 Million USD |
Valuation Analysis
Below Book Valuation: The market values Arcadia Biosciences Inc's assets below their book value (0.14x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Arcadia Biosciences Inc's assets decreased by 31.4% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Arcadia Biosciences Inc (2012–2024)
The table below shows the annual total assets of Arcadia Biosciences Inc from 2012 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $13.52 Million | -31.40% |
| 2023-12-31 | $19.70 Million | -31.87% |
| 2022-12-31 | $28.92 Million | -34.15% |
| 2021-12-31 | $43.92 Million | -7.24% |
| 2020-12-31 | $47.35 Million | +45.36% |
| 2019-12-31 | $32.57 Million | +35.59% |
| 2018-12-31 | $24.02 Million | +44.98% |
| 2017-12-31 | $16.57 Million | -70.71% |
| 2016-12-31 | $56.57 Million | -23.80% |
| 2015-12-31 | $74.24 Million | +198.29% |
| 2014-12-31 | $24.89 Million | +160.84% |
| 2013-12-31 | $9.54 Million | -28.57% |
| 2012-12-31 | $13.36 Million | -- |
About Arcadia Biosciences Inc
Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief,… Read more